Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (새로운 창 열기)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Source‎: Intensive Care Med 2013;39(11):2011-9.

Indexed‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (새로운 창 열기)

Pediatric red blood cell transfusions increase resource use. (새로운 창 열기)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Source‎: J Pediatr 2003;142(2):123-7.

Indexed‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (새로운 창 열기)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (새로운 창 열기)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Source‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexed‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (새로운 창 열기)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (새로운 창 열기)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Source‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexed‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (새로운 창 열기)

Economic evaluation of cell salvage in pediatric surgery. (새로운 창 열기)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Source‎: Paediatr Anaesth 2013;23(11):1027-34.

Indexed‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (새로운 창 열기)